Table 2.
Disease (n) | CFH | CD46 | CFI | CFB | C3 | CFHR5 | ADAMTS13 | THBD | DGKE | PLG | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
TMA (147) | 14 | 9 | 10 | 1 | 8 | 4 | 10 | 2 | 3 | 4 | 65 |
aHUS (118) | 12 (4)a | 9 (3) | 8 (2) | 1 | 7 (1) | 2 | 6 | 3 (2) | 3 | 51 | |
TTP (6) | 1 (1) | 2 | 1 | 4 | |||||||
aHUS/TTPb (12) | 1 | 1 | 2 | 1 | 1 | 6 | |||||
Other (11) | 1 | 1 (1) | 2 (1) | 4 | |||||||
C3G (37) | 6 | 0 | 2 | 3 | 5 | 1 | 1 | 1 | 3 | 1 | 23 |
C3GN (30) | 5 | 1 | 3 | 3 (2) | 1 | 1 | 1 | 2 | 1 | 18 | |
DDD (5) | 1 | 1 | 2 | 4 | |||||||
C3GN/DDDb (2) | 1 | 1 | |||||||||
Other (9) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 3 |
SLE (4) | 0 | ||||||||||
ARF (2) | 0 | ||||||||||
IgAN (2) | 1 | 2 | 3 | ||||||||
Acute GN (1) | 0 |
Variant count: total (novel); novel variants are not reported in any database or literature.
Ambiguous diagnostic information was provided for some patients.